Perrigo Company plc (PRGO)
Data as of Nov 3, 12:52 PM ETPrices may be delayedHow our data works
Res / Sup are automatic swing levels for educational reference only — not signals or advice.
Prices may be delayed. For informational purposes only — not investment advice.
PRGO key stats
PRGO GlowScore: Quiet
A 0–100 read on today's activity from volume, momentum and intraday range. Not a buy or sell signal.
About Perrigo Company plc
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
What's moving PRGO today
Updated November 3, 2026As of November 3, 2026, Perrigo Company plc (PRGO) stock slipped to $15.60, down 0.95% (-$0.15) versus the previous close. On the day, shares have traded between $15.41 and $15.78. That puts PRGO around the middle of its 52-week range of $9.23 to $20.62. Perrigo Company plc operates in the pharmaceutical preparations space and carries a market capitalization of roughly $2.19 billion, with about 560.8K shares changing hands.
Latest PRGO news
- Perrigo (PRGO) Rebounds as Bad News Turns Less BadYahoo Finance· Nov 3, 9:36 AM ET
- Perrigo exits infant-formula with sale to MeridianMadejust-food.com· Oct 30, 9:23 AM ET
- Stryker (SYK) Q3 Earnings and Revenues Lag EstimatesYahoo Finance· Oct 29, 4:35 PM ETSYK
- Perrigo Announces Quarterly DividendYahoo Finance· Oct 29, 12:30 PM ET
- Perrigo Announces Agreement to Divest Infant Formula Business to MeridianMadeYahoo Finance· Oct 29, 9:00 AM ET
- Earnings Preview: Perrigo (PRGO) Q3 Earnings Expected to DeclineYahoo Finance· Oct 28, 9:00 AM ET
- Perrigo to Release Third Quarter 2026 Financial Results on November 4, 2026Yahoo Finance· Oct 21, 8:30 AM ETET
- Abbott (ABT) Misses Q3 Earnings EstimatesYahoo Finance· Oct 21, 7:45 AM ETABT
Source: Yahoo Finance RSS · Updated November 3, 2026
Want PRGO headlines, alerts and AI research in one place? Create a free account →
PRGO buzz on Stocktwits
2,125 watchers$PRGO Perrigo sells infant formula business to MeridianMade for up to $175M. The exit advances Perrigo's plan to become a more focused consumer self-care company and should cut its future capital spending.
@TheDailyBuyout· Oct 30, 5:05 PM ET
$PRGO Still would like to see a weekly 20 MA touch before the next leg up. Either before earnings or after 👀
@Jleon1793· Oct 30, 3:00 PM ET
$PRGO divesting infant formula. That is a huge win. Back to 30 and on up.
@Leapyfroggy· Oct 30, 7:04 AM ET
$PRGO Dividend declared! Great!
@Lidrja· Oct 29, 5:06 PM ET
$PRGO Perrigo is looking constructive here. Price retested the Stage 2 breakout area and found support around the 8 EMA / 21 DMA structure. Nice bounce and healthy price action so far 👀
@KirRoyalTrader· Oct 29, 11:22 AM ET
Source: Stocktwits. User posts are opinions, not verified facts. See what's trending →
PRGO Congress & insider trades
Congress amounts are the disclosed ranges; filings can lag the trade date by up to 45 days.
AI research on PRGO
Get an instant AI breakdown of the bull & bear case, key risks, and what analysts are watching.
Not financial advice. This page is for educational purposes only. Data comes from third-party sources, may be delayed or incomplete, and should not be the basis of any investment decision.